Author:
Wang H,Zhang T,Sun W,Wang Z,Zuo D,Zhou Z,Li S,Xu J,Yin F,Hua Y,Cai Z
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference48 articles.
1. Ottaviani G, Jaffe N . The epidemiology of osteosarcoma. Cancer Treat Res 2009; 152: 3–13.
2. Bielack S, Carrle D, Casali PG . Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20 (Suppl 4): 137–139.
3. Luetke A, Meyers PA, Lewis I, Juergens H . Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev 2014; 40: 523–532.
4. Lin CM, Singh SB, Chu PS, Dempcy RO, Schmidt JM, Pettit GR et al. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study. Mol Pharmacol 1988; 34: 200–208.
5. Greene LM, Meegan MJ, Zisterer DM . Combretastatins: more than just vascular targeting agents? J Pharmacol Exp Ther 2015; 355: 212–227.
Cited by
184 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献